nPhase Secures $30 Million in Series D Funding
nPhase raised $30 million in Series D funding to scale its enterprise clinical data business and support global expansion of its AI-native platform for life sciences.
nPhase raised $30 million in Series D funding to scale its enterprise clinical data business and support global expansion of its AI-native platform for life sciences.